Oct. 20, 2021 Price forecast | 2 weeks: -2.31% | 1 month: -2.34% | 3 months: -3.61%


SWTX stock forecast

Our latest prediction for SpringWorks Therapeutics Inc's stock price was made on the Oct. 20, 2021 when the stock price was at 58.81$.

In the short term (2weeks), SWTX's stock price should underperform the market by -2.31%. During that period the price should oscillate between -9.30% and +10.34%.

In the medium term (3months), SWTX's stock price should underperform the market by -3.61%. During that period the price should oscillate between -30.47% and +23.60%.

Create a solid portfolio with SWTX

Add SWTX to your portfolio and optimize it!


About SpringWorks Therapeutics Inc

SpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. SpringWorks has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers. SpringWorks' strategic approach and operational excellence in clinical development have enabled it to rapidly advance its two lead product candidates into late-stage clinical trials while simultaneously entering into multiple shared-value partnerships with industry leaders to expand its portfolio.

At the moment the company generates 35M USD in revenues.

On its last earning announcement, the company reported a loss of -1.80$ per share.

The book value per share is 5.59$

SpringWorks Therapeutics Inc website


Three months stock forecastOct. 20, 2021


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
35M - -87M -249.00% -87M -1.80 - - 47M 5.59 -54M - -55M